LifeArc is delighted to launch a new Technology Transfer Fellowship programme in partnership with Imperial Innovations, Queen Mary Innovation and UCL Business (UCLB).
Invalid or expired token..
The study explores the potential for the use of antibody-drug conjugates (ADCs) in extracellular, inhibitory applications.
Great Ormond Street Hospital Children’s Charity (GOSH Charity) and LifeArc, a leading UK medical research charity, today announce the launch of a new joint funding scheme: ‘Translational Research Accelerator Grants’ open primarily to research active health professionals at GOSH.
Here we look back at the experiences of last years’ alumni and hope to provide insight into the programme for future candidates.
LifeArc and C4X Discovery join forces to develop small molecule drug candidates active against a high value, novel oncology and inflammation target.
LifeArc, a medical research charity, has signed an agreement to review Asthma UK’s research portfolio, aiming to identify promising projects and results which are most suited to development into treatments.
LifeArc is delighted to announce the appointment of Diana Sternfeld as its new Head of Intellectual Property (IP), effective 12th November 2018. Diana brings a wealth of life sciences experience, supporting and managing the IP needs of the biopharmaceutical industry.
London, UK, September 4th, 2018: LifeArc, one of the UK’s leading medical research charities, is delighted to announce…
London, UK, 31 August 2018: LifeArc®, one of the UK’s leading medical research charities, proudly announces that its…